State lawmakers should not allow the ACC to hold taxpayers hostage with demands for millions of dollars in subsidies.
Price Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Limiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
Regulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
The Convoluted Saga of Maryland’s Purple Line Continues
Since its inception, the Purple Line has been beset by mismanagement, corruption, and delays.
Vaping Saves Lives
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
Unused Cellphones Cost Taxpayers Millions
Mismanagement and a lack of oversight led to the VA wasting taxpayer dollars.
GAO Report Offers Solutions to Duplicative and Overlapping Expenditures
The GAO’s recommendations for 2022 that would add to the $522 billion in savings that have been achieved to date.